LIVER INJURY MARKERS IN DECOMPENSATED HEART FAILURE: PHENOTYPES, CLINICAL AND PROGNOSTIC VALUE ArticleSoloveva A.E., Bayarsaikhan M., Villevalde S.V., Kobalava Z.D.Экспериментальная и клиническая гастроэнтерология. 2018. С. 45-51
РАСПРОСТРАНЕННОСТЬ СИНДРОМА ХСН У ЛИЦ С НОЗОКОМИАЛЬНОЙ ПНЕВМОНИЕЙ В МНОГОПРОФИЛЬНОМ СТАЦИОНАРЕ И ДИАГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ NT PRO BNP ArticleЗоря О.Т., Петров А.А., Омар С.А., Рачина С.А., Кобалава Ж.Д.Материалы VII Всероссийской конференции "Противоречия современной кардиологии: спорные и нерешенные вопросы". 2018. С. 95-96
CARDIAC DYSFUNCTION IN ALCOHOLIC LIVER CIRRHOSIS ArticleIvanov A.S., Romanova V.A., Kolesnikova I.A., Arisheva O.S., Garmash I.V., Kobalava Z.D.Экспериментальная и клиническая гастроэнтерология. 2018. С. 52-57
THE EFFECTS OF DURATION OF HEMODIALYSIS ON THE PARAMETERS OF CENTRAL & PERIPHERAL HEMODYNAMICS IN PATIENTS WITH END-STAGE RENAL DISEASE ArticleTrukhanova M., Orlov A., Tolkacheva V., Villevalde S., Kobalava Z.NEPHROLOGY DIALYSIS TRANSPLANTATION. Том 33. 2018. С. 532-532
VOLUME-COMPRESSIVE OSCILLOMETRY AS NEW BLOOD PRESSURE-MEASURING DEVICE ArticleShavarova E., Padaryan S., Kobalava Z.Journal of Hypertension. Том 36. 2018.
ASSOCIATION BETWEEN THE POLYMORPHICLOCI OF IL-6 (RS1800795)AND IL-8 (RS4073) GENES WITH THE LEVEL OF THE CORRESPONDING CYTOKINES IN THE BLOOD SERUM IN ACUTE ALCOHOLICHEPATITIS ArticleIvanov A.S., Garmashch I.V., Arisheva O.S., Terebilina N.N., Baronets V.Yu., Peregud D.I., Kobalava Zh.D.Трудный пациент. Том 16. 2018. С. 24-28
GERIATRIC SYNDROMES ARE COMMON AND ASSOCIATED WITH ISCHEMIC AND BLEEDING RISK IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROME ArticleSoseliya N., Lobzhanidze B., Bagmanova N., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 20. 2018. С. 123-124
ANTIVIRAL ACTIVITY, SAFETY, AND TOLERABILITY OF MULTIPLE ASCENDING DOSES OF ELBASVIR OR GRAZOPREVIR IN PARTICIPANTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE-1 OR -3 ArticleYeh W.W., Fraser I.P., Jumes P., Petry A., Lepeleire I.D., Robberechts M., Reitmann C., Huang X., Guo Z., Panebianco D., Nachbar R.B., O'mara E., Wagner J.A., Butterton J.R., Dutko F.J., Moiseev V., Kobalava Z., Hüser A., Visan S., Schwabe C. ...Clinical Therapeutics. Том 40. 2018. С. 704-718.e6
EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION ArticleKobalava Z.D., Villevalde S.V., Meray I.A., Shkolnikova E.E., Lukina O.I.Rational Pharmacotherapy in Cardiology. Том 14. 2018. С. 210-216
ABOUT FUNDAMENTAL AND CLINICAL ASPECTS OF MAGNESIUM AND RIBOLAVINE SYNERGIC ACTION IN THERAPEUTIC PRACTICE ArticleGromova O.A., Torshin I.J., Kobalava Z.D., Sorokina M.A.Терапия. 2018. С. 119-131
URINE BIOMARKERS AS DETERMINANTS OF POOR OUTCOMES IN PATIENTS WITH ACUTE KIDNEY INJURY AND HEART FAILURE WITH MID-RANGE EJECTION FRACTION ArticleKlimenko A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 20. 2018. С. 413-413
ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: THE AXIS OF ROTATION BETWEEN THE POLES OF RISK ArticleKobalava Z.D., Shavarov A.A.Евразийский кардиологический журнал. 2018. С. 64-83
MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF THE ARTERIAL IN YOUNG PATIENTS WITH TYPE 1 DIABETES MELLITUS ArticleMedvedev D.A., Mahamat K., Efimova V.P., Safarova A.F., Kobalava Zh.D.Трудный пациент. Том 16. 2018. С. 32-36
SGLT2 INHIBITORS: RATIONALE AND PERSPECTIVES OF USE IN HEART FAILURE ArticleКобалава Ж.Д., Лазарев П.В., Виллевальде С.В.Kardiologiia. Том 58. 2018. С. 44-54
PRACTICAL ASPECTS OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION ArticleКобалава Ж.Д., Шаваров А.А.Kardiologiia. Том 58. 2018. С. 42-55